Apollo Hospitals Ltd reported a 14.2% year-on-year growth in net profit at Rs 233 crore for the July-September quarter.
However, the hospital operator recorded higher-than-expected revenue of Rs 4,846.9 crore, representing a 14% year-on-year increase.
Its EBITDA was reported at Rs 627 crore compared to Rs 565 crore in the same period last year, according to a statement. The EBITDA margin for the July-September quarter was 12.90%, down from 13.3% during the previous corresponding quarter.
As of September 30, Apollo Hospitals has 7,765 operational beds (excluding AHLL and managed beds) across the network, of which 5,051 were occupied beds. Overall hospital occupancy was 68%, up from 62% in the previous quarter, thanks to a significant rise in patient flows across institutions.
Diagnostics and the Retail Healthcare Division Apollo Health and Lifestyle Limited recorded gross sales of Rs 354.2 crore, an increase of 11% year-on-year.
The subsidiary recorded offline pharmacy distribution revenues of Rs 1,714.3 crore and digital platform revenues of Rs 231.2 crore. Overall Health Co revenues were Rs 1,945.4 crore, a 17% increase year-on-year.
At around 10.55 AM, Apollo Hospitals was trading 0.63% lower at Rs 5,264 per piece, against the previous close of Rs 5,297.60 on NSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.